Editorial: Inhibitory Receptors and Pathways of Lymphocytes

Alexandre M Carmo^{1

2}, Paul E Love³, Aaron J Marshall⁴

Affiliations

¹ IBMC - Instituto de Biologia Molecular e Celular, Porto, Portugal.
² i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
³ Section on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States.
⁴ Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Editorial

Alexandre M Carmo et al. Front Immunol. 2020.

. 2020 Jul 22:11:1552.

doi: 10.3389/fimmu.2020.01552. eCollection 2020.

Alexandre M Carmo^{1

2}, Paul E Love³, Aaron J Marshall⁴

¹ IBMC - Instituto de Biologia Molecular e Celular, Porto, Portugal.
² i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
³ Section on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States.
⁴ Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

No abstract available

Keywords: autoimmunity; cancer; checkpoint blockade; immunotherapy; inhibitory receptor; inhibitory signaling; lymphocyte.

Comment on

Editorial on the Research Topic Inhibitory Receptors and Pathways of Lymphocytes